AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL
Prescription Only
Drug type: Therapeutic
ATC code: J07BX05
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION
Route of administration: INTRAMUSCULAR
Active ingredient: RSVPreF3 antigen; RSVPreF3 antigen
Registrant
GLAXOSMITHKLINE PTE LTD
Approval Date
2024-05-10
Approval Number
SIN17008P
Manufacturer
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA (adjuvant)
GlaxoSmithKline Vaccines S.r.l. (adjuvant)
